Evidence map›Paper›PMID 36624162›Full record

ArticleBone marrow transplantation2023

Splenic irradiation prior to allogeneic hematopoietic cell transplantation for patients with myelofibrosis.

John R Bales, Haesook T Kim, Roxana Portillo, Chirayu Patel, Steven McAfee, Bimalangshu Dey, Thomas Spitzer, Yi-Bin Chen, Areej El-Jawahri, Zachariah DeFilipp and 1 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Myelofibrosis: Timing of Transplantation and Management of Splenomegaly.Advances in experimental medicine and biology · 2025
    Review
  6. Are transplant indications changing for myelofibrosis?Hematology. American Society of Hematology. Education Program · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

John R BalesDepartment of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Haesook T KimDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Roxana PortilloDepartment of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Chirayu PatelDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Steven McAfeeHematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Bimalangshu DeyHematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Thomas SpitzerHematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1384-5742
Yi-Bin ChenHematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-9554-1058
Areej El-JawahriHematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-3556-1495
Zachariah DeFilippHematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-7994-8974
Gabriela S HobbsDepartment of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. ghobbs@partners.org.ORCID 0000-0002-0199-9333
Harvard University · USDana-Farber Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationPrimary MyelofibrosisHumansSpleenTransplantation Conditioning

Identifiers

PMID36624162
OpenAlexW4313886040

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.